Jefferies Boosts Price Target on Caribou Coffee (CBOU) After Solid Q4
Tweet Send to a FriendGet Alerts CBOU Hot Sheet
Price: $15.99 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade CBOU Now!
Jefferies raised its price target on Caribou Coffee (NASDAQ: CBOU) from $17 to $22 following Q4 EPS of $0.14, above the consensus of $0.13 and CPG +78% & SSS +5.6% drove upside despite cost headwind. The firm noted '12 EPS guidance was reiterated, but EPS much more 2H-weighted due to infl comparisons. "Strong CPG biz & reaccel of unit gr, impressive SSS & pricing flex paint a compelling growth opportunity"
The firm said valuation is attractive at 8.5x EV/ ’13 EBITDA & 1.1x PEG ('13).
Jefferies trimmed Q1 EPS from $0.08 to $0.04, but FY12 was maintained at $0.50.
For an analyst ratings summary and ratings history on Caribou Coffee click here. For more ratings news on Caribou Coffee click here.
Shares of Caribou Coffee closed at $17.59 yesterday, with a 52 week range of $8.50-$18.24.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm said valuation is attractive at 8.5x EV/ ’13 EBITDA & 1.1x PEG ('13).
Jefferies trimmed Q1 EPS from $0.08 to $0.04, but FY12 was maintained at $0.50.
For an analyst ratings summary and ratings history on Caribou Coffee click here. For more ratings news on Caribou Coffee click here.
Shares of Caribou Coffee closed at $17.59 yesterday, with a 52 week range of $8.50-$18.24.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Lifts Numbers on Diana Shipping (DSX) Post Q1
- Wedbush Expects Positive Results from Insmed (INSM) ARIKAC Trial
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

